Cronos Group Inc. Common Share (CRON) — 分析摘要
Cronos Group Inc. Common Share（CRON）的市值为1.18十亿美元，最近一年的营收同比增长了+24.6%。净利润率为-6.4%。当前市盈率为16.9倍。
核心要点
- 营收同比变化+24.6%
- 净利润率-6.4%
- 市盈率16.9倍
与MEDICINAL CHEMICALS & BOTANICAL PRODUCTS板块的其他公司相比，CRON的营收增长为+24.6%，市盈率为16.9倍。
Cronos Group Inc. Common Share (CRON)
前收盘价 2026-10-12 · 市场数据 POLYGON · 财务数据 SEC EDGAR
红旗与风险提示无重大红旗
基于最新财报，没有触发重大的信用、利润率或趋势红旗。
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
行业
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
员工人数
610
总部
STAYNER, A6
Exchange
XNAS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析，不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
免责声明：本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。